A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000
Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000
A Case of Lithium-Induced Asterixis
J Am Geriatr Society 48:457, Stewart,J.T. & Williams, L.S., 2000
Infection Related to Intracranial Pressure Monitors in Adults: Analysis of Risk Factors and Antibiotic Prophylaxis
JNNP 69:381-384, Rebuck,J.A. et al, 2000
Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000
Wernicke-Korsakoff Encephalopathy and Polyneuropathy After Gastroplasty for Morbid Obesity
Arch Neurol 57:1356-1359, Cirignotta,F. et al, 2000
Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging
Stroke 31:2175-2181, Oppenheim,C. et al, 2000
Heroin-Induced Spongiform Leukoencephalopathy: Value of Diffusion MF Imaging
J Comput Assist Tomog 24:735-737, Chen,C.,et al, 2000
Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000
Iatrogenic Creutzfeldt-Jakob Disease at the Millenium
Neurol 55:1075-1081, Brown,P.,et al, 2000
Tonic Seizures are a Particular Risk Factor for Drowning in People with Epilepsy
BMJ 321:975-976, Besag,F.M.C., 2000
Significance of Surgical Resection for the Treatment of Multiple Brain Metastases
Anticancer Res 20:573-577, Iwadate,Y.,et al, 2000
Moyamoya-like Vasculopathy from Cocaine Dependency
AJNR 21:1008-1010, Storen,E.C.,et al, 2000
Familial Form of Intracranial Cavernous Angioma:MR Imaging Findings in 51 Families
Radiology 214:209-216, Brunereau,L.,et al, 2000
Carotid Endarterectomy, A Neurotherapeutic Advance
Arch Neurol 57:40-45, Barnett,H.J.M.&Meldrum,H.E., 2000
Ischemia After Carotid Endarterectomy:Comparison between Transcranial Doppler Sonography and Diffusion-Weighted MR Imaging
AJNR 21:47-54,41, Muller,M.,et al, 2000
Incidence of Postangiographic Abnormalities Revealed by Diffusion-Weighted MR Imaging
AJNR 21:55-59, Britt,P.M.,et al, 2000
Status Epilepticus In Stroke, Report on a Hospital-Based Stroke Cohort
Neurol 54:350-354, Rumbach,L.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Incidence and Prognostic Significance of Fever Following Intracerebral Hemorrhage
Neurol 54:354-361, Schwarz,S.,et al, 2000
Identification of Patients at Risk for Periprocedural Neurological Deficits Associated with Carotid Angioplasty and Stenting
Stroke 31:376-382, Qureshi,A.I.,et al, 2000
Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000
Intraspinal Hemorrhage Complicating Oral Anticoagulant Therapy, An Unusual Case of Cervical Hematomyelia and a Review of the Literature
Arch Int Med 160:237-240, Pullarkat,V.A.,et al, 2000
A Randomized Trial of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Neurol 54:603-607, Sanders,D.B.,et al, 2000
Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000
Weak and Numb Feet in a Man with Knobby Hands, Report of a Case
Arch Neurol 57:271, Kaplan,P.W.,et al, 2000
The Risk of Abducens Palsy after Diagnostic Lumbar Puncture
Neurol 54:768-769, Thomke,F.,et al, 2000
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Transient Ischaemic Attack in a Young Woman
Lancet 355:622, Lee,P. & Tse, H., 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Arterial Dissections Complicating Cerebral Angiography and Cerebrovascular Interventions
AJNR 21:541-545, Cloft,H.J.,et al, 2000
Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
MR Characteristics of Muslin-Induced Optic Neuropathy: Report of Two Cases and Review of the Literature
AJNR 21:346-352, Bhatti,M.T.,et al, 2000
Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
The Central Nervous system and Infection by Candida Species
Diagn Microbial Infect Dis 37:169-179, Sanchez-Portocarrero, J.,et al, 2000
Bicuspid Aortic Valve - A Silent Danger: Analysis of 50 Cases of Infective Endocarditis
Clin Inf Dis 30:336-341, Lamas, C.C. & Eykyn, S.J., 2000
Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999
Pneumocephalus Following Inadvertent Intrathecal Puncture During Epidural Anesthesia: A Case Report and Review of the Literature
J Matern Fetal Med 8:138-140, Sherer,D.M.,et al, 1999
Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999
CT and MR Imaging of Neurocysticercosis
AJR 173:1485-1490, Noujaim,S.E.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999